Huaier granules for protein in urine from lung cancer treatment
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether Huaier granules, a Chinese herbal medicine, can reduce protein in the urine caused by bevacizumab or anlotinib treatment for lung cancer. If you're experiencing this side effect, the trial may help manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of lung cancer.
- You must be currently receiving either bevacizumab or anlotinib treatment.
- You must have protein in your urine, with a 24-hour protein level between 0.15 g and 3.5 g.
- You must be able to take oral medication and have not used Huaier granules in the past month.
- You must not have other causes of proteinuria (like kidney disease or high blood pressure) or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether Huaier Granule, a traditional Chinese medicine, can help reduce protein in the urine (proteinuria) in people with breast cancer who are undergoing or have had immunotherapy. The goal is to see if this treatment can protect your kidneys and improve your quality of life during cancer therapy.
This study tests whether a traditional Chinese herbal medicine called Huaier granules can help lower tumor marker levels in the blood of people who have been treated for breast cancer. Tumor markers are substances that can indicate whether cancer is present or active; lowering them may be a sign that the cancer is under control.
This trial tests whether Huaier granules, a traditional Chinese medicine, can help people with advanced breast cancer that has not spread to major organs like the liver or lungs. You may join if you've had no more than one prior treatment and your cancer is not curable with surgery or radiation.
This study tests whether Huaier granules can help prevent lung cancer from coming back after surgery. It is for people with stage II–IIIA non-small cell lung cancer who have recently had their tumor completely removed and have not had other treatments like chemotherapy or radiation.
This trial studies whether Huaier granules can improve kidney disease activity in people with “idiopathic membranous nephropathy” who test positive for PLA2R antibodies and are still not in remission. Participants will also have been on standard blood-pressure/kidney-protecting treatment (called RASI) for at least 4 weeks.
This trial tests whether a Chinese herbal medicine called Huaier granules works better than standard chemotherapy for people with pancreatic cancer that was removed by surgery. Participants can choose to take Huaier granules or standard chemotherapy, and researchers will compare outcomes.
Hear when a new Proteinuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.